Clinical trials
Multiple Sclerosis, Chronic Progressive trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Active, not recruiting | 4 |
| Completed | 4 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Novartis Pharmaceuticals | 3 |
| Biogen | 2 |
| Sanofi | 2 |
| Hasselt University | 1 |
| MedDay Pharmaceuticals SA | 1 |
| University Hospital of Mont-Godinne | 1 |
| University Hospital, Antwerp | 1 |
| University Hospital, Ghent | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 15 |
| Multiple Sclerosis | 7 |
| Autoimmune Diseases of the Nervous System | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognition Disorders | 1 |
| Demyelinating Autoimmune Diseases, CNS | 1 |
| Fatigue | 1 |
| Multiple Sclerosis, Relapsing-Remitting | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.